Cas:42521-08-4 2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE manufacturer & supplier

We serve Chemical Name:2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE CAS:42521-08-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE

Chemical Name:2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE
CAS.NO:42521-08-4
Synonyms:2,6-Dichloropyridine-4-carbonyl chloride;MFCD00052639
Molecular Formula:C6H2Cl3NO
Molecular Weight:210.44500
HS Code:2933399090

Physical and Chemical Properties:
Melting point:23-25°C
Boiling point:140 °C
Density:1.537
Index of Refraction:1.579
PSA:29.96000
Exact Mass:208.92000
LogP:2.76740

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3261
Packing Group:


Contact us for information like 2,6-Dichloropyridine-4-carbonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00052639 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00052639 Use and application,MFCD00052639 technical grade,usp/ep/jp grade.


Related News: Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. 2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE manufacturer Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE supplier The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. 2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE vendor Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. 2,6-DICHLOROPYRIDINE-4-CARBONYL CHLORIDE factory Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.